This is a centrally acting analgesic with twin mechanisms of action — binding weakly to μ-opioid receptors and at the same time inhibiting the reuptake of serotonin and norepinephrine. This synergistic strategy will make Tramadol not simply a painkiller, but a comprehensive Option for an array of agony syndromes, which includes those unresponsiv